Clinical Data's Fiscal Q2 Revenue Up 25 Percent on Strong Cogenics, PGxHealth Sales | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical Data said today that fiscal second-quarter 2008 revenues swelled 25 percent as R&D spending fell 10 percent and net loss rose 34 percent.
 
Total receipts for the three months ended Sept. 30 increased to $9.1 million from $7.3 million in the second fiscal quarter of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.